Folia Pharmacologica Japonica
Latest Publications

TOTAL DOCUMENTS

5304

(FIVE YEARS 305)

H-INDEX

24

(FIVE YEARS 1)

Published By The Japanese Pharmacological Society

1347-8397, 0015-5691

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Preface

Folia Pharmacologica Japonica ◽

10.1254/fpj.21054 ◽

2022 ◽

Vol 157 (1) ◽

pp. 26-26

Author(s):

Hiroyuki Sugiyama

Download Full-text

The effect of bioactive substances derived from gut bacteria on the development of allergic diseases

Folia Pharmacologica Japonica ◽

10.1254/fpj.21088 ◽

2022 ◽

Vol 157 (1) ◽

pp. 85-85

Author(s):

Sae Yamamoto ◽

Takahisa Murata

Keyword(s):

Allergic Diseases ◽

Gut Bacteria ◽

Bioactive Substances

Download Full-text

The 72nd Regional Meeting (Kita Area)

Folia Pharmacologica Japonica ◽

10.1254/fpj.s21098 ◽

2022 ◽

Vol 157 (Supplement) ◽

pp. S1-S34

Keyword(s):

Regional Meeting

Download Full-text

Th2 cytokines in pulmonary fibrosis

Folia Pharmacologica Japonica ◽

10.1254/fpj.21096 ◽

2022 ◽

Vol 157 (1) ◽

pp. 86-86

Author(s):

Kyoko Endo

Keyword(s):

Pulmonary Fibrosis ◽

Download Full-text

Involvement of muscle stem cell in skeletal muscle hypertrophy induced by mechanical loading and drugs

Folia Pharmacologica Japonica ◽

10.1254/fpj.21047 ◽

2022 ◽

Vol 157 (1) ◽

pp. 23-25

Author(s):

So-ichiro Fukada

Keyword(s):

Skeletal Muscle ◽

Stem Cell ◽

Mechanical Loading ◽

Muscle Hypertrophy ◽

Muscle Stem Cell ◽

Skeletal Muscle Hypertrophy

Download Full-text

Preface

Folia Pharmacologica Japonica ◽

10.1254/fpj.21073 ◽

2022 ◽

Vol 157 (1) ◽

pp. 3-3

Author(s):

Takashi Murayama ◽

Toshiko Yamazawa

Download Full-text

Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome)

Folia Pharmacologica Japonica ◽

10.1254/fpj.21080 ◽

2022 ◽

Vol 157 (1) ◽

pp. 62-75

Author(s):

Ryuji Yamamoto ◽

Satoshi Kawashima

Keyword(s):

Clinical Study ◽

Mechanism Of Action ◽

Pharmacological Property ◽

Hunter Syndrome ◽

Mucopolysaccharidosis Type ◽

Type Ii ◽

Mucopolysaccharidosis Type Ii ◽

Download Full-text

How to evaluate skeletal muscle function: suggestion from studies on skeletal muscle fatigue

Folia Pharmacologica Japonica ◽

10.1254/fpj.21065 ◽

2022 ◽

Vol 157 (1) ◽

pp. 9-14

Author(s):

Daiki Watanabe ◽

Keita Kanzaki ◽

Masanobu Wada

Keyword(s):

Skeletal Muscle ◽

Muscle Fatigue ◽

Muscle Function ◽

Skeletal Muscle Function ◽

Skeletal Muscle Fatigue

Download Full-text

COVID-19 drug candidate pipeline, an overview

Folia Pharmacologica Japonica ◽

10.1254/fpj.21043 ◽

2022 ◽

Vol 157 (1) ◽

pp. 27-30

Author(s):

Hiroyuki Sugiyama

Keyword(s):

Download Full-text

Pharmacological profile, clinical efficacy, and safety of Follitropin Delta produced by recombinant DNA technology in a human cell line (REKOVELLE® PEN for S.C. Injection 12 μg, 36 μg, 72 μg)

Folia Pharmacologica Japonica ◽

10.1254/fpj.21079 ◽

2022 ◽

Vol 157 (1) ◽

pp. 76-84

Author(s):

Yoshiharu Abe ◽

Yasushi Ozeki

Keyword(s):

Cell Line ◽

Clinical Efficacy ◽

Recombinant Dna ◽

Human Cell Line ◽

Efficacy And Safety ◽

Pharmacological Profile ◽

Recombinant Dna Technology ◽

Download Full-text